Compare BioNTech SE - ADR (BNTX) vs VanEck JP Morgan EM Local Currency Bond ETF (EMLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs VanEck JP Morgan EM Local Currency Bond ETF — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while VanEck JP Morgan EM Local Currency Bond ETF trades at $25.6. The key difference: VanEck JP Morgan EM Local Currency Bond ETF is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | EMLC | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | Fixed Income |
52-Week High | $119.34 | $26.59 |
52-Week Low | $83.89 | $24.83 |
Enterprise Value | $6.60B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →
